Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →
Concordare secures a funding round to accelerate the digitization of clinical trial protocols, enhancing efficiency. This funding will support their innovative technology that automates workflows in clinical trials.
PRIVATEAug 25, 2026•about 4 hours ago
Round Type
Venture - Series Unknown
New YorkBiotechnologyHealth CareDescription
Concordare converts clinical trial protocols into a digital format, automating workflows that reduce the time, cost and error rate of clinical trials. The funding will help further develop their technology and streamline clinical trial processes.
Don't miss Concordare's next move
Get an email the moment Concordare raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Concordare raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.